is Australia’s largest provider of pathology testing and the third largest in the world, with operations in eight countries.
Sonic Genetics is a specialist genetics service that brings together Sonic Healthcare’s national and international expertise to provide a comprehensive range of high quality, accredited genetic tests to doctors, patients and families across Australia.
Our MIBC 2018 presentation focuses on the TGA registered Prosigna® Breast Cancer Prognostic Gene Signature Assay which provides a patient’s risk of distant recurrence and classifies tumours into one of four intrinsic subtypes to guide clinical decisions. Prosigna® is based on the PAM50 gene signature that measures the expression of 50 genes.
Prosigna® is performed in an accredited Australian laboratory and provides clinicians with the most comprehensive and actionable results at a cost-effective price. For further information, please come to our booth, visit www.sonicgenetics.com.au/tests/prosigna
or call us on 1800 010 447.